Back to search
FDAFDA · Food and drugs·Recall number D-0444-2023

Phenylephrine HCl 40 mg (160 mcg/mL) added to 0.9% Sodium Chloride 250 mL IV Bag, Leiter Compounding Health 13796 Compark Blvd Englewood CO 80112, NDC 71449-150-82

Published March 15, 2023 · Recall initiated: February 21, 2023

Summary

FDA records drug Class II recall D-0444-2023, published March 15, 2023 and initiated February 21, 2023. Recalling firm: Denver Solutions, LLC DBA Leiters Health; Status: Terminated; Reported quantity: 1212 units; Lot: Lot #: 2231017, Exp. Date 3/12/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP DEVIATIONS

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Denver Solutions, LLC DBA Leiters Health
Distributor
Nationwide within the United States including VA or other Government facilities
Lot
Lot #: 2231017, Exp. Date 3/12/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Phenylephrine HCl 40 mg (160 mcg/mL) added to 0.9% Sodium Chloride 250 mL IV Bag, Leiter Compounding Health 13796 Compark Blvd Englewood CO 80112, NDC 71449-150-82 recalled?

Yes. FDA published recall D-0444-2023 on March 15, 2023. Reported hazard: CGMP DEVIATIONS

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail